Today: 12 May 2026
NANO Nuclear Stock Jumps as Supermicro AI Data Center Pact Puts Microreactors in Play
6 May 2026
2 mins read

NANO Nuclear Stock Jumps as Supermicro AI Data Center Pact Puts Microreactors in Play

New York, May 6, 2026, 15:06 (EDT)

  • NANO Nuclear and Super Micro Computer have agreed to a non-binding MOU, with plans to assess the potential for on-site nuclear energy at AI data centers.
  • NNE surged roughly 24.6% by mid-afternoon in New York. Supermicro moved higher, too, following a better-than-forecast outlook.
  • This deal remains in the exploratory phase—there’s no signed customer contract, no revenue forecast, and no reactor approval at this point.

NANO Nuclear Energy Inc. said Wednesday it’s entered a non-binding memorandum of understanding with Super Micro Computer Inc., targeting the use of NANO’s microreactors as a power source for AI data centers. The collaboration would look at integrating NANO’s KRONOS MMR energy system alongside Supermicro’s server racks, AI hardware, cooling solutions and support services.

The deal comes as power supply is tightening for the AI sector. On Wednesday, Reuters reported that Microsoft is considering pushing back or even scrapping its 2030 clean-power matching target, pressured by surging data-center demand. Exelon, for its part, has increased its capital spending plan, pointing directly to robust power needs and the expansion of data centers.

NANO sees the deal as a potential entry point to hyperscale, enterprise, and edge data-center markets—well ahead of any commercial reactor rollout. The memorandum of understanding, or MOU, just lays out a framework for talks and collaboration; it doesn’t lock in a supply contract.

NANO jumped 24.6% to $28.37 by 18:49 UTC, putting its market cap around $1.41 billion. Supermicro tacked on 21.4% to close at $33.78. Other advanced nuclear stocks moved higher as well: NuScale Power advanced 12.0%, Oklo climbed 13.9%.

Supermicro delivered a fresh jolt of its own, posting fiscal Q3 net sales of $10.2 billion. Looking ahead, the company projected fourth-quarter sales between $11 billion and $12.5 billion. CEO Charles Liang put it plainly: the shift to a full-scale datacenter infrastructure provider is picking up speed.

Jay Yu, chairman and president of NANO, described AI as “fundamentally an energy challenge.” CEO James Walker said the companies are working toward “compute and power becoming a unified solution”—echoing what data-center operators across the industry are after: a dedicated electricity supply, sidestepping grid delays. GlobeNewswire

KRONOS MMR, built by the company, is a micro modular reactor aimed at delivering nuclear energy on a much smaller scale than standard plants. On March 31, the University of Illinois Urbana-Champaign announced that its Grainger College of Engineering filed a construction permit application with the U.S. Nuclear Regulatory Commission. The move comes in partnership with NANO, as they seek to bring a KRONOS reactor to the university’s campus.

NANO is still in its early days. According to its latest quarterly filing, the company had brought in no material revenue from inception through Dec. 31, 2025, with losses totaling $64.0 million. Management said more funding will be needed as reactors progress toward commercialization. Cash and cash equivalents stood at roughly $578 million at the close of 2025.

Execution remains the biggest question mark. NANO acknowledged in the MOU filing that there’s no guarantee it will progress to binding deals or any revenue-making projects. The company pointed to regulatory hurdles, design and testing requirements, the risk of going over budget, a need for more funding, and the timing for commercial rollout as ongoing sources of uncertainty.

So, investors get a simpler narrative, but the business case remains untested. The Supermicro deal hooks NANO Nuclear Energy into the hot AI power demand trend. Still, the real challenge is coming: moving from an early-stage agreement to actual licensed hardware, signed customers, and bringing in revenue.

Stock Market Today

  • Wall Street Slides as AI Stocks Falter and Oil Prices Rise Amid Iran Conflict
    May 12, 2026, 5:23 PM EDT. Wall Street paused its record-setting rally as AI stocks declined and oil prices climbed amid tensions with Iran. The S&P 500 dropped 0.2% from its previous high, while the Nasdaq slipped 0.7%. Dow Jones Industrial Average rose slightly by 56 points. Significant losses hit chipmakers: Intel fell 6.8%, Micron Technology 3.6%, trimming strong year-to-date gains. South Korea's Kospi also dropped 2.3%, spooked by potential AI profit redistribution. Brent crude surged 3.4% to $107.77 a barrel due to Strait of Hormuz restrictions from the Iran war. Rising oil costs worsened U.S. inflation, surpassing forecasts, with Treasury yields climbing to 4.45%. Investors anticipate the Federal Reserve may maintain or hike interest rates amid persistent inflation concerns.

Latest article

Tesla Stock Falls as Hot Inflation and Robotaxi Doubts Test the AI Premium

Tesla Stock Falls as Hot Inflation and Robotaxi Doubts Test the AI Premium

12 May 2026
Tesla shares fell 2.7% to $433.45 after U.S. inflation data pushed Treasury yields higher and Reuters reported long waits and spotty robotaxi service in Texas. The stock swung from a high of $447.56 to a low of $422.39. Tesla’s valuation remains near $1.53 trillion, with a price-to-earnings ratio close to 398. Management cited cautious robotaxi rollout and increased 2026 capital spending above $25 billion.
Ernexa Stock’s 58% Jump Shows How Fast a Tiny Biotech Can Reprice on Ovarian-Cancer Hopes

Ernexa Stock’s 58% Jump Shows How Fast a Tiny Biotech Can Reprice on Ovarian-Cancer Hopes

12 May 2026
Ernexa Therapeutics shares jumped 58.5% to $11.43 Tuesday after renewed investor focus on its preclinical ovarian-cancer therapy ERNA-101, following a May 11 investor event. Trading volume reached about 18.85 million shares. The company reported $8.3 million in cash as of April 30, less than needed for its 12-month plan, and may use an at-the-market stock sale to raise funds.
UnitedHealth Stock Climbs as Investors Reprice the Turnaround, Not Just the Latest Headline

UnitedHealth Stock Climbs as Investors Reprice the Turnaround, Not Just the Latest Headline

12 May 2026
UnitedHealth shares climbed 3.1% to $396.45 Tuesday after unveiling a new Optum Rx fee-based pricing model and raising 2026 profit guidance. The company reported Q1 revenue of $111.7 billion and adjusted earnings of $7.23 per share. Management said fundamentals are improving but described the turnaround as ongoing. Investors responded to both the PBM overhaul and stronger earnings outlook.
Why Ernexa Therapeutics Stock Jumped After ERNA-101 Ovarian Cancer Survival Data
Previous Story

Why Ernexa Therapeutics Stock Jumped After ERNA-101 Ovarian Cancer Survival Data

NICE Stock Tumbles After an Earnings Beat. The Guidance Is Why
Next Story

NICE Stock Tumbles After an Earnings Beat. The Guidance Is Why

Go toTop